ISSCR News
Global Stem Cell Research Community Gathers in Kyoto, Japan to Celebrate 20 Years of iPSC Discovery and Innovation
Sold-out ISSCR symposium underscores extraordinary global interest in stem cell science, from fundamental discoveries to clinical translation and emerging stem cell therapies
The International Society for Stem Cell Research (ISSCR) today opens its international symposium celebrating the 20th anniversary of induced pluripotent stem (iPS) cell technology, bringing together scientists, clinicians, and innovators from around the world to reflect on two decades of transformative discoveries and explore the future of stem cell research and regenerative medicine.
The three-day symposium, held 20–22 October in Kyoto, Japan, is organized in partnership with the Center for iPS Cell Research and Application (CiRA) and co-sponsored by the Japanese Society for Regenerative Medicine (JSRM).
The extraordinary response to the symposium underscores the strength and momentum of stem cell science worldwide. Registration reached capacity twice, even after the ISSCR expanded the meeting to a larger venue to accommodate growing demand. This remarkable level of interest reflects both the profound impact of iPSC technology over the past two decades and the expanding opportunities ahead, from fundamental discoveries in human biology to advances in disease modeling, drug discovery, clinical translation, and the development of stem cell-based therapies.
ISSCR 2027 Annual Meeting Opens Registration and Abstract Submissions
The field’s premier convening returns to San Francisco, 15-18 June 2027, spanning breakthroughs in basic biology, advances in disease modeling and drug discovery, and new clinical data on cell-based therapies, with AI advancing work across all three.
The International Society for Stem Cell Research (ISSCR) has opened registration and abstract submissions for the ISSCR 2027 Annual Meeting, taking place 15-18 June 2027 at Moscone West in San Francisco, California, USA. Marking the 25th anniversary of the ISSCR Annual Meeting, this hallmark event will bring together the global stem cell community to share groundbreaking discoveries, explore transformative technologies, and advance the future of stem cell science and regenerative medicine.
The ISSCR Recognizes Outstanding Poster Award Winners at the ISSCR 2026 Annual Meeting in Montreal
The International Society for Stem Cell Research (ISSCR) has recognized five outstanding scientists with Poster Awards at the ISSCR 2026 Annual Meeting, honoring innovative research spanning developmental biology, disease modeling, regenerative medicine, and functional genomics.
Selected from more than 1,300 scientific posters presented during the meeting, the awards recognize exceptional research and scientific communication. Winning posters were evaluated by senior stem cell scientists attending the meeting, underscoring the rigor and peer recognition behind the awards.
New First-in-Human Study Presented at ISSCR 2026 Explores Immune-Engineered Cell Therapy Approach for Type 1 Diabetes
Research evaluates whether hypoimmune cell engineering can help transplanted insulin-producing cells survive without chronic immunosuppression
New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells can survive and function without chronic immunosuppression.
The study addresses one of the field’s central challenges: overcoming immune rejection, which has limited the broader use of islet and stem cell-based replacement therapies for type 1 diabetes.
Stem Cell Strategy for Chronic Spinal Cord Injury Advances
New preclinical findings and updated clinical trial plans presented today at ISSCR 2026 highlight a tailored stem cell approach designed to overcome the long-standing barriers of chronic paralysis
New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting highlights a significant step toward developing a stem cell-based treatment for chronic spinal cord injury (SCI), a condition for which no effective restorative therapy currently exists.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .